Wall Street analysts expect that Proto Labs, Inc. (NYSE:PRLB) will post $80.11 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Proto Labs’ earnings, with estimates ranging from $80.00 million to $80.21 million. Proto Labs reported sales of $74.96 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 6.9%. The business is scheduled to issue its next earnings results before the market opens on Thursday, July 27th.

On average, analysts expect that Proto Labs will report full-year sales of $80.11 million for the current year, with estimates ranging from $326.80 million to $328.62 million. For the next financial year, analysts expect that the business will post sales of $357.94 million per share, with estimates ranging from $354.40 million to $361.48 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Proto Labs.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Thursday, April 27th. The industrial products company reported $0.51 EPS for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.11. The business had revenue of $80.20 million during the quarter, compared to the consensus estimate of $75.05 million. Proto Labs had a return on equity of 11.84% and a net margin of 14.48%. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 earnings per share.

Several brokerages have recently issued reports on PRLB. Zacks Investment Research raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Wednesday, May 3rd. TheStreet raised shares of Proto Labs from a “c+” rating to a “b-” rating in a research report on Friday, May 5th. Finally, Dougherty & Co raised their target price on shares of Proto Labs from $42.50 to $45.00 and gave the company a “sell” rating in a research report on Friday, April 28th.

Proto Labs (PRLB) traded down 1.61% during trading on Thursday, reaching $70.50. 100,580 shares of the company’s stock traded hands. The company has a market cap of $1.87 billion, a P/E ratio of 42.22 and a beta of 0.93. Proto Labs has a 12 month low of $43.10 and a 12 month high of $72.15. The firm’s 50 day moving average is $67.11 and its 200 day moving average is $57.80.

In other news, Director Rainer Gawlick sold 833 shares of the firm’s stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $64.05, for a total transaction of $53,353.65. Following the completion of the sale, the director now owns 6,258 shares in the company, valued at approximately $400,824.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John B. Tumelty sold 11,896 shares of the firm’s stock in a transaction dated Monday, May 8th. The stock was sold at an average price of $61.72, for a total transaction of $734,221.12. Following the sale, the director now owns 4,299 shares of the company’s stock, valued at approximately $265,334.28. The disclosure for this sale can be found here. Company insiders own 7.78% of the company’s stock.

Hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Proto Labs by 146,773.4% in the first quarter. BlackRock Inc. now owns 2,905,155 shares of the industrial products company’s stock valued at $148,453,000 after buying an additional 2,903,177 shares during the period. Norges Bank acquired a new stake in shares of Proto Labs during the fourth quarter valued at $24,400,000. Handelsbanken Fonder AB boosted its stake in shares of Proto Labs by 676.7% in the second quarter. Handelsbanken Fonder AB now owns 466,036 shares of the industrial products company’s stock valued at $31,341,000 after buying an additional 406,036 shares during the period. Lazard Asset Management LLC acquired a new stake in shares of Proto Labs during the first quarter valued at $8,416,000. Finally, Brown Capital Management LLC boosted its stake in shares of Proto Labs by 2.9% in the first quarter. Brown Capital Management LLC now owns 3,801,528 shares of the industrial products company’s stock valued at $194,258,000 after buying an additional 107,183 shares during the period.

TRADEMARK VIOLATION WARNING: “$80.11 Million in Sales Expected for Proto Labs, Inc. (PRLB) This Quarter” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/07/20/80-11-million-in-sales-expected-for-proto-labs-inc-prlb-this-quarter.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.